Proper neural activity: A bioisosteric replacement approach allowed the identification of a use-dependent sodiumchannel blocker (17 a) with low P-glycoprotein-mediated active transport across the blood-brain barrier and a cytoprotective effect on HeLa cells. The target residues involved in binding hNav1.4 were identified by molecular docking studies.
适当的神经活动:生物等排替代方法允许鉴定一种使用依赖性钠通道阻滞剂 ( 17a ),它具有低 P-糖蛋白介导的跨血脑屏障的主动转运和对 HeLa 细胞的细胞保护作用。通过分子对接研究确定了参与结合 hNav1.4 的目标残基。